- Sturey B, Patnaik A. Neutrophils and Anti-cancer Immunity: A Paradigm Shift in Cancer Immunotherapy. Oncoscience 2017; 4(11-12):164-165. PMID: 29344550.
- Li Y, Malapati S, Lin Y, Patnaik A. Challenges with sequencing therapies in metastatic castrate-resistant prostate cancer. American Journal of Hematology/Oncology 2017; 13 (12): 26-31.
- Carlo MI, Giri MN, Antonarakis ES, Abida W, Alumkal JJ, Beer TM, Beltran H, George DJ, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Ryan CJ, Schaeffer EM, Stadler W, Taplin ME, Kauff ND, Paller CJ, Vinson J,Cheng HH. Evolving Intersection between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium. JCO Precis Oncol. 2018; 1: 1-14.
- Sharma-Saha S, Sturey R, Duttagupta P, Patnaik A. Harnessing the Power of Precision Medicine to Enhance Responsiveness to Cancer Immunotherapy. Immunology 2018; Accepted.
- Patnaik A, Swanson KD, Csizmadia E, Solanki A, Landon-Brace N, Gehring M, Helenius K, Olson BM, Pyzer AR, Wang LC, Elemento O, Novak J, Thornley TB, Asara JM, Montaser L, Timmons JJ, Morgan TM, Wang Y, Levantini E, Clohessy JG, Kelly K, Pandolfi PP, Rosenblatt JM, Avigan DE, Ye H, Karp JM, Signoretti S, Balk SP and Cantley LC. Cabozantinib eradicates advanced murine prostate cancer by activating anti-tumor innate immunity. Cancer Discovery. 2017; PMID: 28274958.
- ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer. Gao S, Ye H, Gerrin S, Wang H, Sharma A, Chen S, Patnaik A, Sowalsky AG, Voznesensky O, Han W, Yu Z, Mostaghel E, Nelson PS, Taplin ME, Balk SP, Cai C. Clin Cancer Res. 2016 Mar 2.
- Mahoney K, Gupta M, Patnaik A. Isolated Ovarian Metastasis in an Elderly Woman with a Prior History of Superficial Bladder Cancer. Clin Med Rev Case Rep. 2015; 2:064.
- González-Billalabeitia* E, Seitzer N* (co-first author), Song SJ, Song MS, Patnaik A, Liu XS, Epping MT, Papa A, Hobbs R, Chen M, Lunardi A, Webster KA, Signoretti S, Loda M, Asara J, Nardella C, Cantley LC, Pandolfi PP. p53 Status Dictates Differential Response to PARP inhibition upon PTEN-loss. Cancer Discovery. 2014; 4(8): 896-904. PMID: 24866151.
- Fendt S, Bell E, Keibler M, Davidson M, Wirth G, Fiske B, Mayers J, Patnaik A, Bellinger G, Csibi A, Blenis J, Cantley L, Guarente L, Pollak M, Olumi A, Vander Heiden M, Stephanopoulos G. Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Res. 2013; 73:4429-38. PMID: 23687346.
- Lunardi A, Nardella C, Ala U, Salmena L, Webster KA, Wang G, Lis R, Stack EC, Patnaik A, Wong KK, Engelman JA, Cantley LC, Bubley G, Gerald WL, Montironi1 R, Signoretti S, Loda M, Pandolfi PP. “Co-Clinical” identification of novel genetic determinants and molecular mechanisms underlying prostate cancer resistance to androgen deprivation. Nat Genet. 2013; 45(7):747-55. PMID: 23727860.
- Nardella C, Lunardi A, Patnaik A, Cantley LC, Pandolfi PP. The APL Paradigm and the “Co-Clinical Trial” Project. Cancer Discovery. 2011; 1:108-116. PMCID: PMC3222327.
- Giorgia Z, Carmen P, Patnaik A, Loda M. New strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK. Clin Can Res. 2010; 16(13): 3322-8. PMCID: PMC3176306.
- Shaywitz AJ*, Courtney KD*, Patnaik A*, Cantley LC (*Equal contribution). PI3K Enters Beta Testing. Cell Metab. 2008; 8:179-81. PMCID: PMC3389549.
- Spidel JL, Craven RC, Wilson CB, Patnaik A, Wang H, Mansky LM, Wills, JW. Lysines Close to the Rous Sarcoma Virus Late Domain Critical for Budding. J. Virol. 2004; 78:10606-16. PMCID: PMC516377.
- Patnaik A, Wills JW. In vivo interference of Rous Sarcoma Virus budding by cis expression of a WW domain. J. Virol. 2002; 76:2789-95. PMCID: PMC135952.
- Patnaik A, Chau V, Li F, Montelaro RC, Wills, JW. Budding of Equine Infectious Anemia Virus is Insensitive to Proteasome Inhibitors. J. Virol. 2002; 76:2641-47. PMCID: PMC135976.
- Patnaik A, Chau V, Wills, JW. Ubiquitin is a component of the retrovirus budding machinery. Proc. Natl. Acad. Sci. USA. 2000; 97:13069-74. PMCID: PMC27179.
